This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, eHealth) (353) Games and Gamification for Health (650) Serious Games for Health and Medicine (683) Anxiety and Stress Disorders (1053)
Protocol for Co-Design, Development, and Open Trial of a Prototype Game-Based eHealth Intervention to Treat Anxiety in Young People With Long-Term Physical Conditions

Protocol for Co-Design, Development, and Open Trial of a Prototype Game-Based eHealth Intervention to Treat Anxiety in Young People With Long-Term Physical Conditions

Protocol for Co-Design, Development, and Open Trial of a Prototype Game-Based eHealth Intervention to Treat Anxiety in Young People With Long-Term Physical Conditions

Authors of this article:

Hiran Thabrew1 Author Orcid Image ;   Karolina Stasiak1 Author Orcid Image ;   Sally Merry1 Author Orcid Image
Article Authors Cited by (6) Tweetations (5) Metrics

    Protocol

    University of Auckland, Department of Psychological Medicine, Auckland, New Zealand

    Corresponding Author:

    Hiran Thabrew, B BiomedSci (Hons), BMed, FRACP, FRANZCP

    University of Auckland

    Department of Psychological Medicine

    Level 12 Support Block

    Auckland Hospital, Park Road, Grafton

    Auckland, 1149

    New Zealand

    Phone: 64 21402055

    Email: h.thabrew@auckland.ac.nz


    Background: Approximately 10% to 12% of New Zealand young people (and 21% of Maori young people) have long-term physical conditions and are more likely to develop psychological problems, particularly anxiety and depression. Delayed treatment leads to worse management of physical conditions, school absence, and poorer long-term outcomes. Recently, electronic health (eHealth) interventions have been shown to be as good as face-to-face therapy and biofeedback techniques have been shown to enhance relaxation during the treatment of anxiety. In addition, young people with long-term physical conditions have expressed a preference for more technologically based support, including game-based interventions, to deal with psychological issues, particularly anxiety.

    Objective: The aim of this study is to develop a prototype game-based eHealth intervention to address anxiety in young people with long-term physical conditions. The game will be based on the principles of cognitive behavior therapy (CBT) and will integrate a module of biofeedback-based relaxation.

    Methods: During the first phase of the study, up to 48 young people with long-term physical conditions aged 13 to 18 years, attending a tertiary pediatric hospital will be invited to participate in a 3-stage series of co-design workshops. Following the design, development, and refinement of a working prototype, during the second phase of the study, a further 20 young people with long-term physical conditions and anxiety will be recruited from the same location to participate in an open pilot trial to evaluate its acceptability, usability, and preliminary efficacy.

    Results: Changes in anxiety will be measured using the Generalized Anxiety Disorder 7-item scale (GAD-7) and the Spence Child Anxiety Scales (SCAS) at the end of every module (recommended to be completed weekly), post intervention, and 3 months later. Usability of the intervention will be measured using the System Usability Scale (SUS) and by measuring frequency and quantity of use of the intervention. Acceptability of the intervention will be assessed using brief, open-ended questionnaires and semi-structured interviews, the data from which will be analyzed using a general inductive approach. Recruitment to the study commenced in January 2017 and data collection will be completed by the end of December 2017.

    Conclusions: If acceptable and useful, this game-based eHealth intervention may offer a cost-effective and clinically useful intervention for addressing the psychological needs of over 16,000 young people with long term health conditions in New Zealand.

    Trial Registration: Australian New Zealand Clinical Trials Network Registry (ANZCTR): ACTRN12616001253493p; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371443 (Archived by WebCite at http://www.webcitation.org/6sYB716lf)

    JMIR Res Protoc 2017;6(9):e171

    doi:10.2196/resprot.7250

    Keywords

    long-term physical conditions; chronic illness; anxiety; eHealth; gaming; young people; treatment; cognitive behavior therapy; biofeedback 


    Long-term physical conditions are increasingly common in children and young people and those that last more than 3 months and impair functioning affect 10% to 12% of children globally [1]. These conditions include asthma, diabetes, epilepsy, and obesity, among others [2,3]. The prevalence of long-term physical conditions in childhood is increasing [4] and in some high-income countries, due to improvements in hygiene, immunization, and access to medical care, it is greater than that of acute illness [5].

    Psychological problems, especially anxiety, are more likely in these individuals such that long-term physical conditions in children have consistently been associated with an increased risk of psychological problems [6-11], particularly anxiety which has been identified in up to 40% of these individuals [12]. The likelihood of anxiety is related to young people’s developmentally linked internal ability to manage stress, to family factors, and the cumulative allostatic load-related impact of illness and treatment, particularly distress and pain [13,14]. Anxiety and other psychological problems can occur during or even following the completion of medical (eg, cancer) treatment [15] and may be associated with school absence, poor academic performance, and lower health-related quality of life [16,17]. Left untreated, anxiety disorders tend to have a chronic and unremitting course [18] and tend to increase the risk for adult psychiatric disorders, including depression and substance use disorders [19].

    Access to, and effectiveness of, treatments for these problems are currently limited. Psychological problems are traditionally addressed using psychotherapies such as cognitive behavior therapy (CBT) and pharmacotherapy (eg, anxiolytic or antidepressant medication). There is limited evidence that these therapies are effective for children with long-term physical conditions [20]. Psychotherapies are often not accessible and although 60% of children with anxiety who receive CBT show an adequate treatment response [21], there does appear to be room for improving current treatment.

    With the increasing popularity of smart technology, release of app-based interventions, and calls from international organizations such as The Lancet Global Mental Health Group [22] for the introduction of innovative and accessible cognitive and behavioral strategies to treat anxiety, depressive, and other common mental health problems, electronic health (eHealth) interventions may have a useful role to play in addressing common mental health problems in young people with long-term physical conditions. Health games, such as Smart, Positive, Active, Realistic, X-factor Thoughts (SPARX) [23], have already been shown to be as good as face to face treatment for addressing depression in young people. Similar interventions such as Body Signs, Relaxation, Active Helpful Thoughts, Victory Over Your Fears, Enjoy (BRAVE) online [24] exist to treat anxiety but are not focused on health-related anxieties and are not widely available outside Australia. During a recent investigation by Thabrew and colleagues, young people with long-term physical conditions identified anxiety as the most significant psychological issue that they face. Together with their families and clinicians, they confirmed limited knowledge of and access to eHealth interventions and expressed support for the development of eHealth interventions targeted towards their needs [25].

    Traditional psychological therapies often include a component of psychologically or chemically induced relaxation and there is increasing evidence that newer, more technologically-based forms of therapy, such a biofeedback, may achieve similar results, either alone or in combination with traditional therapies [26]. Furthermore, some biofeedback interventions have already been combined with game-based technology to reduce stress or treat behavior disorders [27]. Biofeedback involves the use of electrical or electro-mechanical equipment to measure physiologic processes occurring in a person and then feed this information back to them to develop a greater awareness and ability to control changes within their bodies with and without equipment [28] and improve health and performance [29]. There are a number of types of biofeedback including heart rate variability (HRV), electroencephalography (EEG), and pneumography (PNG). HRV is already used by some pediatric mental health teams in New Zealand (personal communication from Dr Louise Webster, Starship Hospital, Auckland) and a recent systematic review by Dr Thabrew supported further research into HRV biofeedback as a treatment for anxiety (in press).

    The aims of this study are (1) to develop a prototype game-based eHealth intervention for treating anxiety in young people with long-term physical conditions via co-design with end-users at Starship Hospital; (2) to evaluate the acceptability of this intervention with its intended audience; (3) to evaluate the utility of this intervention with its intended audience; (4) to evaluate the efficacy of this intervention in a preliminary manner; and (5) to evaluate the feasibility of delivery of this intervention with its intended audience.


    Research Strategy

    The study will employ a mixed-methods design to co-design, produce, and test a prototype game-based eHealth intervention for treating anxiety in young people with long-term physical conditions.

    Study Design

    The study will involve 2 phases. During the first phase, a prototype game-based eHealth intervention will be designed and refined via a co-design process with young people with long-term physical conditions attending a tertiary pediatric hospital in Auckland, New Zealand. Three stages of iterative consultation are planned, with 4 focus groups of up to 12 participants at each stage. At least one focus group at each stage will be arranged for Māori young people to ensure that, in the spirit of biculturalism, the intervention is culturally acceptable to them. By the end of this phase, a working prototype that is ready for pilot testing will be created and refined to ensure it is compatible with end-user expectations. During the second phase, an open pilot trial will be undertaken with 20 young people with long-term physical conditions and anxiety from the same hospital. Each will be loaned a portable device (iPad or similar tablet) on which the prototype intervention, questionnaires, and scales will be preloaded. They will be given up to 8 weeks to complete the intervention at a speed and frequency of their choosing.

    Study Population

    Up to 48 young people with long-term physical conditions who are either inpatients or outpatients attending a tertiary pediatric hospital in Auckland, New Zealand will participate in focus groups during each stage of the first phase. Following this, 20 young people will then participate in the second phase, open trial.

    Inclusion Criteria

    Young people will be included in the first phase of the study if they are aged between 13 to 18 years, have any long-term physical condition over 3 months duration (eg, asthma, diabetes, cancer, cystic fibrosis), are of any ethnicity, do and do not have a known anxiety disorder, do or do not have any co-morbid mental health condition, can intellectually and physically use the device and intervention, and if they understand English and are able to provide informed consent or assent. Young people will be included in the second phase of the study if they meet all of the above criteria and have any symptoms of anxiety (not necessarily a diagnosed anxiety disorder).

    Exclusion Criteria

    Young people will be excluded from participation if they do not meet all of the inclusion criteria, if they have an intellectual disability or cannot speak English, or if they have recently undertaken or are undertaking CBT or other forms of psychotherapy, biofeedback therapy, or pharmacotherapy with anxiolytic medication, as these may confound the effectiveness of the prototype game-based eHealth intervention.

    Intervention

    The prototype game-based eHealth intervention that will be co-designed with young people with long-term physical conditions will be a 4 to 8 module online, game-based intervention. Its content will be based on the principles of CBT and include an integrated or associated biofeedback-based relaxation component. It is anticipated that modules will take between 30 to 60 minutes each to be completed. Key elements that will be included are education about anxiety and coping strategies for anxiety, using one’s body (relaxation strategies), mind (recognizing unhelpful thoughts and cognitive restructuring), and actions (including graded exposure) to beat anxiety. The precise format and look of the prototype game-based eHealth intervention will be designed in conjunction with end users. The prototype intervention will be stored on a portable tablet, rather than available online or via a mobile app. Due to the co-design process that is being planned, the precise form and content of the intervention is not yet fully defined. However, key CBT-based principles including psychoeducation, relaxation, graded exposure to feared stimuli, and cognitive restructuring will be included. Further refinement of the intervention is likely on the basis of feedback from the pilot trial.

    Outcome Measures

    The primary outcomes of the study are (1) acceptability of the prototype intervention, (ie, is the content and format acceptable to users), as assessed via a semi-structured interview following completion of the study at 8 weeks; (2) utility of the intervention (ie, is it useful), as assessed using the System Utility Scale (SUS) [30] following completion of the intervention at 8 weeks; and (3) feasibility of the intervention (ie, is it easy to deliver in a hospital/home setting), as assessed via a semi-structured interview following completion of the study at 8 weeks.

    The secondary outcome of the study is efficacy (ie, does the intervention reduce anxiety and related issues). This will be assessed by measuring changes over time in the Generalized Anxiety Disorder, 7-item (GAD-7) [31], Spence Children’s Anxiety Scale (SCAS) [32], and the Pediatric Quality of Life Inventory (PedsQL) [33], as outlined in the schedule below (Table 1). The GAD-7 is a newer, brief scale for measuring anxiety that may be useful to incorporate into the final version of the intervention for ease of completion. The SCAS is a well-validated, 46-item self-report scale measuring child anxiety via an overall score and 6 subscales for panic/agoraphobia, social phobia, separation anxiety, obsessions/compulsions, fear of physical injury, and generalized anxiety. It has sound psychometric properties with internal consistency reported at 0.92 for the total child score. The PedsQL is a well-validated, 23-item self or parent report scale measuring quality of life. It has good internal consistency (0.88 for total scale), validity, and acceptability. It reliably distinguishes between healthy children and those with acute or long-term physical conditions.

    Statistical Methodology

    Quantitative data will be analyzed using Microsoft Excel and Statistical Software Package (SPSS). Analyses will include basic descriptive statistics (eg, number of sessions completed, number of times device accessed, duration of use, changes in anxiety score, and demographic characteristics of the sample). McNemar’s chi-square tests and t tests will be used to assess the statistical significance of changes in anxiety scores over time. P values of less than .05 will be taken to indicate statistical significance and 95% confidence intervals will be used to establish the extent of any difference between pre- and post-measures. A sample size of 20 will enable detection of changes within the study group with effect sizes of 0.65 or more as statistically significance (alpha .05 with 80% power). Qualitative data will be analyzed using a general inductive approach. Collated text analyzed to identify emerging themes, which will then be independently coded by one researcher and a subset of 30% of results, will be cross-coded. NVIVO software will be used to handle transcripts.

    Table 1. Schedule of assessment procedures.

    		BaselineDuring interventionPost intervention3-month follow-up
    DemographicsYes


    GAD-7aYesAt the completion of each moduleYesYes
    SCASbYesAt the completion of each moduleYesYes
    PedsQLcYes
    		Yes
    SUSd

    		Yes
    Online tracking
    		As used

    Semi-structured questionnaire

    		YesYes

    aGAD-7: Generalized Anxiety Disorder, 7-item.

    bSCAS: Spence Children’s Anxiety Scale.

    cPedsQL: Pediatric Quality of Life Inventory.

    dSUS: System Utility Scale.

    Table 2. Timelines of the study.
    PhaseTasksTimeframe
    Phase 1Ethics approval, securing of fundingSeptember 2016 to December 2016

    		Prototype development via co-design with young people and in conjunction with software company and engineersJanuary 2017 to December 2017
    Phase 2Recruitment of participants for open trialSeptember 2017 to December 2017

    		Open trialJanuary 2018 to June 2018

    		Analysis of results, write-up, and dissemination of study resultsJuly 2018 to December 2018

    Timeline

    The expected timelines of the study are shown in Table 2.

    Equipment Required

    An initial working CBT-based prototype intervention will be created in conjunction with a software developer and computer engineer. Biofeedback will be applied via a crude and cost-effective hybrid (most likely an existing HRV-based device that is not fully integrated into the new CBT-based intervention, but used with it). Study participants will be loaned an iPad or similar device on which the necessary technology and analysis software has been pre-loaded.

    Ethics and Consent

    This study received ethics approval from the New Zealand Health and Disability Ethics Committee (16/CEN/136) on the 30th of September 2016. Invitations to the co-design focus groups and pilot study will be forwarded to potential participants through clinicians at Starship Hospital to minimize coercion by direct approach. Consent will be obtained directly for those over 16 years of age and via their parents with participant assent for those under 16 years of age. Participants will be free to discontinue engagement at any stage without consequence and this will be made clear to them. Should any unanticipated distress occur during participation, immediate referral will be undertaken to the hospital-based pediatric consult liaison (mental health) team. Data will be presented in a de-identified manner and will be securely stored for 10 years as per University of Auckland regulations.


    Participant recruitment for the first phase of this study commenced in January 2017 and recruitment of participants for the second phase of the study will commence in September 2017. Completion of recruitment is anticipated to occur in June 2018 and analysis of results will be undertaken by December 2018.


    Principal Findings

    Anxiety disorders are among the top causes of disability adjusted life years (DALYs) in New Zealand [34] and are the most common type of mental disorder of childhood with a prevalence of 11% in international cohorts [35]. Based on 2013 New Zealand census data [36], we estimate there are over 400,000 young people aged 12 to 18 years in New Zealand. If 10% of them have a long-term physical condition, and up to 40% of this cohort is at risk of an anxiety disorder, that means that over 16,000 children in New Zealand could directly benefit from an intervention that is specifically designed for their needs.

    Following the completion of this study, the prototype new game-based eHealth intervention will be refined into a final version for testing in a randomized controlled trial (RCT). If shown in this subsequent study to be clinically effective and acceptable in its final form, it is hoped that the intervention may be hosted on a national eHealth platform and will be made available free of charge to young people in New Zealand. This is currently the case with SPARX, a computerized intervention for depression, but this is contingent on funding from the Ministry of Health.

    Conclusion

    The potential health impact of this intervention includes improved access to an acceptable and evidence-based treatment for anxiety in young people with long-term physical conditions and an improvement in the management of both psychological and physical conditions. The potential social impact of such an intervention includes improved functioning for young people with long-term physical conditions by means of reduced school absence, improved social integration, and better relationships with family and clinical teams.

    Short-term, the potential economic impact of such an intervention includes reduced cost of intervention (compared to face to face treatment) and reduced parental time off work. Long-term, direct improvements in psychological welfare and indirect improvements in physical welfare are likely to lead to improved chances of completed education and employment. From a service delivery point of view, this intervention could address current resource limitations of mental health services to address the needs of young people with long-term physical conditions.

    Acknowledgments

    This research is being conducted as part of HT’s PhD at the University of Auckland, New Zealand. The material costs of this study and participant salaries are being funded via the Department of Psychological Medicine and HT’s PhD PRESS fund.

    Conflicts of Interest

    None declared.

    1. Eiser C. Effects of chronic illness on children and their families. Adv Psychiatr Treat 1997 Jul 01;3(4):204-210. [CrossRef]
    2. Burkhart PV, Dunbar-Jacob JM, Fireman P, Rohay J. Children's adherence to recommended asthma self-management. Pediatr Nurs 2002;28(4):409-414. [Medline]
    3. Perrin JM, Bloom SR, Gortmaker SL. The increase of childhood chronic conditions in the United States. JAMA 2007 Jun 27;297(24):2755-2759. [CrossRef] [Medline]
    4. van der Lee JH, Mokkink L, Grootenhuis M, Heymans HS, Offringa M. Definitions and measurement of chronic health conditions in childhood: a systematic review. JAMA 2007 Jun 27;297(24):2741-2751. [CrossRef] [Medline]
    5. Halfon N, Newacheck PW. Evolving notions of childhood chronic illness. JAMA 2010 Feb 17;303(7):665-666. [CrossRef] [Medline]
    6. Pless IB, Roghmann KJ. Chronic illness and its consequences: observations based on three epidemiologic surveys. J Pediatr 1971 Sep;79(3):351-359. [Medline]
    7. Cadman D, Boyle M, Szatmari P, Offord DR. Chronic illness, disability, and mental and social well-being: findings of the Ontario Child Health Study. Pediatrics 1987 May;79(5):805-813. [Medline]
    8. Newacheck PW, McManus MA, Fox HB. Prevalence and impact of chronic illness among adolescents. Am J Dis Child 1991 Dec;145(12):1367-1373. [Medline]
    9. Rosenbaum P. Prevention of psychosocial problems in children with chronic illness. CMAJ 1988 Aug 15;139(4):293-295 [FREE Full text] [Medline]
    10. Pao M, Bosk A. Anxiety in medically ill children/adolescents. Depress Anxiety 2011 Jan;28(1):40-49 [FREE Full text] [CrossRef] [Medline]
    11. Marin T, Chen E, Munch T, Miller GE. Double-exposure to acute stress and chronic family stress is associated with immune changes in children with asthma. Psychosom Med 2009 May;71(4):378-384 [FREE Full text] [CrossRef] [Medline]
    12. Denny S, de SM, Fleming T, Clark T, Merry S, Ameratunga S, et al. The prevalence of chronic health conditions impacting on daily functioning and the association with emotional well-being among a national sample of high school students. J Adolesc Health 2014 Apr;54(4):410-415. [CrossRef] [Medline]
    13. Juster R, McEwen B, Lupien S. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev 2010 Sep;35(1):2-16. [CrossRef] [Medline]
    14. Lewis M, Vitulano LA. Biopsychosocial issues and risk factors in the family when the child has a chronic illness. Child Adolesc Psychiatr Clin N Am 2003 Jul;12(3):389-99, v. [Medline]
    15. Sawyer M, Antoniou G, Toogood I, Rice M. Childhood cancer: a two-year prospective study of the psychological adjustment of children and parents. J Am Acad Child Adolesc Psychiatry 1997 Dec;36(12):1736-1743. [CrossRef] [Medline]
    16. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999 Jul;60(7):427-435. [Medline]
    17. Opolski M, Wilson I. Asthma and depression: a pragmatic review of the literature and recommendations for future research. Clin Pract Epidemiol Ment Health 2005 Sep 27;1:18 [FREE Full text] [CrossRef] [Medline]
    18. Ramsawh H, Raffa S, Edelen M, Rende R, Keller M. Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder. Psychol Med 2009 Apr;39(4):615-624 [FREE Full text] [CrossRef] [Medline]
    19. Pine D, Cohen P, Gurley D, Brook J, Ma Y. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998 Jan;55(1):56-64. [Medline]
    20. Bennett S, Shafran R, Coughtrey A, Walker S, Heyman I. Psychological interventions for mental health disorders in children with chronic physical illness: a systematic review. Arch Dis Child 2015 Apr;100(4):308-316 [FREE Full text] [CrossRef] [Medline]
    21. Compton SN, Peris TS, Almirall D, Birmaher B, Sherrill J, Kendall PC, et al. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. J Consult Clin Psychol 2014 Apr;82(2):212-224 [FREE Full text] [CrossRef] [Medline]
    22. Lancet Global Mental Health Group, Chisholm D, Flisher AJ, Lund C, Patel V, Saxena S, et al. Scale up services for mental disorders: a call for action. Lancet 2007 Oct 06;370(9594):1241-1252. [CrossRef] [Medline]
    23. Merry SN, Stasiak K, Shepherd M, Frampton C, Fleming T, Lucassen MFG. The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial. BMJ 2012 Apr 18;344:e2598 [FREE Full text] [Medline]
    24. Holmes J, March S, Spence S. ?Use of the internet in the treatment of anxiety disorders with children and adolescents. ? Counselling, Psychotherapy, and Health 5.1 (2009) 2009:187-231.
    25. Thabrew H, Stasiak K, Garcia-Hoyos V, Merry SN. Game for health: how eHealth approaches might address the psychological needs of children and young people with long-term physical conditions. J Paediatr Child Health 2016 Aug 16. [CrossRef] [Medline]
    26. Schoenberg P, David A. Biofeedback for psychiatric disorders: a systematic review. Appl Psychophysiol Biofeedback 2014 Jun;39(2):109-135. [CrossRef] [Medline]
    27. Knox M, Lentini J, Cummings TS, McGrady A, Whearty K, Sancrant L. Game-based biofeedback for paediatric anxiety and depression. Ment Health Fam Med 2011 Sep;8(3):195-203 [FREE Full text] [Medline]
    28. Culbert TP, Kajander RL, Reaney JB. Biofeedback with children and adolescents: clinical observations and patient perspectives. J Dev Behav Pediatr 1996 Oct;17(5):342-350. [Medline]
    29. Schwartz MS, Andrasik F, editors. Biofeedback, Third Edition: A Practitioner's Guide. New York, NY: Guilford Press; 2003.
    30. Brooke J. SUS: a quick and dirty usability scale. In: Jprdam PW, Thomas B, McClelland IL, Weerdmeester B, editors. Usability Evaluation in Industry. Boca Raton, FL: CRC Press; 1996.
    31. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006 May 22;166(10):1092-1097. [CrossRef] [Medline]
    32. Spence SH, Barrett PM, Turner CM. Psychometric properties of the Spence Children's Anxiety Scale with young adolescents. J Anxiety Disord 2003;17(6):605-625. [Medline]
    33. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001 Aug;39(8):800-812. [Medline]
    34. Ministry of Health. The Burden of Disease and Injury in New Zealand. Wellington, NZ: Ministry of Health; 2001.
    35. Kazak AE. In: Wiener LS, Pao M, Kupst MJ, Farkas Patenaude A, editors. Pediatric Psycho-Oncology: A Quick Reference on the Psychosocial Dimensions of Cancer Symptom Management. Charlottesville, VA: American Psychosocial Oncology Society; 2009.
    36. New Zealand Census Data. 2001.   URL: http://nzdotstat.stats.govt.nz/wbos/Index.aspx [accessed 2017-08-09] [WebCite Cache]
    37. Wiener L, Pao M, Kazak AE, Kupst MJ, Farkas Patenaude A, Holland JC, editors. Quick Reference for Pediatric Oncology Clinicians: The Psychiatric and Psychological Dimensions of Pediatric Cancer Symptom Management. Brentwood, TN: American Psychosocial Oncology Society (APOS); 2009.
    38. New Zealand Government. New Zealand Census Data. Wellington: Statistics New Zealand; 2012.   URL: http://nzdotstat.stats.govt.nz/wbos/Index.aspx [accessed 2017-01-01] [WebCite Cache]

    ‎
    CBT: cognitive behavior therapy
    eHealth: electronic health
    GAD-7: Generalized Anxiety Disorder, 7-item
    HRV: heart rate variability
    PedsQL: Pediatric Quality of Life Scale
    SCAS: Spence Children’s Anxiety Scale
    SPARX: Smart, Positive, Active, Realistic, X-Factor Thoughts
    SUS: System Usability Scale

    Edited by G Eysenbach; submitted 07.05.17; peer-reviewed by T Penders, C Eichenberg; comments to author 17.06.17; revised version received 20.06.17; accepted 14.07.17; published 22.09.17

    Copyright

    ©Hiran Thabrew, Karolina Stasiak, Sally Merry. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 22.09.2017.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.